This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Hemoglobin A1c Monitoring Industry

6. FOCUS ON SELECT GLOBAL PLAYERS II-44

Abbott Laboratories ( USA) II-44

Axis-Shield plc (UK) II-44

Bayer Healthcare Diabetes Care ( USA) II-45

Beckman Coulter, Inc. ( USA) II-45

Bio-Rad Laboratories Inc ( USA) II-45

Diabetes Technologies Inc ( USA) II-46

Geonostics, Inc. ( USA) II-46

HEMOCUE® AB ( Sweden) II-47

Menarini Diagnostics (UK) II-47

Roche Diagnostics ( Switzerland) II-47

Siemens Healthcare Diagnostics ( Germany) II-47

Tosoh Bioscience, Inc ( USA) II-48

Trinity Biotech plc ( Ireland) II-48

7. GLOBAL MARKET PERSPECTIVE II-49

Table 7: World Recent Past, Current and Future Analysis for

HbA1c Monitoring by Geographic Region - US, Europe, and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-49

Table 8: World Historic Review for HbA1c Monitoring by

Geographic Region - US, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-50

Table 9: World 15-Year Perspective for HbA1c Monitoring by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for the Years 2004, 2011

& 2018 (includes corresponding Graph/Chart) II-51

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

An Insight III-1

Current and Future Analysis III-1

Market Dynamics and Trends III-1

HbA1c - Increasingly Moving into Physician's Office III-1

HbA1c Testing for Diabetes Detection Gains Support III-1

ADA Recommends HbA1c Test for Diabetes Diagnosis III-2

Rising Inclination towards CLIA-Waived Tests III-2

Need for Further Stringency in Requirements Arises III-2

5 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs